The Ameliorating Effect of Adipose Tissue Stem Cells on Liver Function in Experimental Rats with Liver Fibrosis

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 165

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJNS-7-4_006

تاریخ نمایه سازی: 19 دی 1401

Abstract:

Background: As mesenchymal stem cells have anti-inflammatory and immunomodulating properties and can be a therapeutic option in regenerative medicine, this study was undertaken to determine ameliorating effect of adipose tissue stem cells (AdSCs) on liver function in experimental rats with liver fibrosis.Methods: Thirty-two rats were randomly divided into four equal groups including control group ۱ receiving just ۱ mL/kg of distilled water, twicea week for ۸ weeks (intraperitoneally: IP). Control group ۲ received ۱mL/kg of olive oil, similarly. Sham group was treated with CCl۴ (۱ mL/kg) dissolved in ۱ mL of olive oil to induce liver injury, identically. In control and sham groups, blood samples were collected at the beginning of week ۸. Finally, the experimental group after induction of liver injury, was injected with ۲×۱۰۶ AdSCs in the tail vein at the beginning of week ۸, while a blood sample was provided after ۳ and ۸ weeks following cell transplantation to determine liver function.Results: AdSC were spindle shape, positive for osteogenic and adipogenic inductions and expressed mesenchymal and lacked hematopoietic markers. Following cell transplantation, an improvement in albumin, total protein, and direct and indirect bilirubin were noticed denoting to repairing effect of AdSCs and treatment of liver injury.Conclusion: AdSCs improved liver function and acted as a promoting factor for liver regeneration. So they can be helpful for ameliorating hepatic injuries. These findings can be beneficial for cell therapy and can open a new era for researchers trying to improve mesenchymal stem cell therapeutic outcomes.

Authors

Davood Mehrabani

Li Ka Shing Center for Health Research and Innovation, University of Alberta, Edmonton, AB, Canada

Samin Arshi

Department of Biology, Islamic Azad University, Arsanjan Branch, Arsanjan, Iran

Ladan Sadeghi

Department of Biology, Islamic Azad University, Arsanjan Branch, Arsanjan, Iran

Zahra Khodabandeh

Stem Cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Shahrokh Zare

Stem Cell Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Mina Rabiee

University of Eastern Finland, Kuopio, Finland